|
 |
|
|
| |
|
Newsletter Sponsor
|
|
Live webinar: Harnessing Emerging Technologies to Obtain the Best Chemical Information from Pharmaceutical Products
Extraneous material, such as micro-particles, found in the manufacturing stream of biopharmaceuticals must be identified and the root cause must be determined to take corrective actions. Biopharmaceuticals differ significantly from conventional pharmaceutics in manufacturing and delivery. They are typically manufactured after molecular cloning by cell culture fermentation, purification by multiple chromatography and filtration steps, and formulated as injectable to bypass the digestive system. Different extraneous material may appear during the many steps of the manufacturing processes.
 |
|
|
|
|
|
|
|
|
 |
Featured Articles |
 |
|
| |
Why Not?
Why Not?
As scientists, we recognize that ours is not a static discipline. We are trained to reflect on the ...
read more » |
 |
|
|
|
|
|
|
| |
|
|
|
|
|
|
Featured Whitepaper |
|
|
| |
Confidence Down the Line: BD Select APS TSB
Confidence Down the Line: BD Select APS TSB
Good manufacturing processes require pharmaceutical companies to regularly perform media fills to verify whether their aseptic procedures are adequate to prevent contamination during drug production. ...
read more »
|
|
Single-Use Powder Containment for Easy, Secure, Flexible Manufacturing
Single-Use Powder Containment for Easy, Secure, Flexible Manufacturing
ILC Dover’s ArmorFlex® Series multi-layered polymer films and DoverPac containment systems provide you with safe, flexible containment solutions that can minimize cross-contamination, ensure patient ...
read more »
|
|
 |
| |
|
|
Events |
|
|
| |
|
|
|
|
PREP 2017
Philadelphia, PA – 07/16/2017
Most recognized international conference where scientists and engineers come from around the world to discuss and learn about the most recent advances...
event details » |
|
|
|
 |
|
|
